Following a limited submission
AWMSG advice |
|||
| Status: Recommended | |||
Triamcinolone hexacetonide is recommended as an option for use within NHS Wales for the treatment of juvenile idiopathic arthritis. |
|||
|
|||
Medicine details |
|||
| Medicine name | triamcinolone hexacetonide | ||
| Formulation | 20 mg/ml suspension for injection | ||
| Reference number | 2527 | ||
| Indication | Treatment of juvenile idiopathic arthritis |
||
| Company | Intrapharm Laboratories Ltd | ||
| BNF chapter | Musculoskeletal & joint diseases | ||
| Submission type | Limited | ||
| Status | Recommended | ||
| Advice number | 1517 | ||
| NMG meeting date | 07/06/2017 | ||
| AWMSG meeting date | 19/07/2017 | ||
| Date of issue | 08/08/2017 | ||
| Date of last review | August 2020 | ||